Teva Pharmaceutical Industries (TEVA) Inventory Average (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Inventory Average came in at $3.2 billion in Q2 2026, down 5.15% YoY from $3.4 billion in Q2 2025, and up 0.66% on a QoQ basis from $3.2 billion in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Inventory Average (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Inventory Average data on file, last reported at $3.2 billion in Q2 2026.
- Quarterly Inventory Average fell 5.15% year-over-year to $3.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 billion (down 5.15% YoY) and the FY2025 annual result came in at $3.1 billion, down 11.98% from the prior year.
- Inventory Average rose to $3.2 billion in Q2 2026, from $3.2 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $4.1 billion in Q2 2023 to a low of $3.1 billion in Q1 2025.
- A 5-year average of $3.7 billion and a median of $3.9 billion in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average grew 4.94% — and 2025, when it declined 21.53%.
- Tracing TEVA's Inventory Average over 5 years: stood at $3.8 billion in 2022, then rose by 4.94% to $4.0 billion in 2023, then dropped by 13.7% to $3.5 billion in 2024, then slipped by 6.66% to $3.3 billion in 2025, then declined by 1.61% to $3.2 billion in 2026.
- The last three Inventory Average figures came in at $3.2 billion (Q2 2026), $3.2 billion (Q1 2026), and $3.3 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Bn |
| Mar 31, 2026 | 3.18 Bn |
| Dec 31, 2025 | 3.25 Bn |
| Sep 30, 2025 | 3.41 Bn |
| Jun 30, 2025 | 3.37 Bn |
| Mar 31, 2025 | 3.13 Bn |
| Dec 31, 2024 | 3.48 Bn |
| Sep 30, 2024 | 3.94 Bn |
| Jun 30, 2024 | 3.94 Bn |
| Mar 31, 2024 | 3.99 Bn |
| Dec 31, 2023 | 4.04 Bn |
| Sep 30, 2023 | 4.08 Bn |
| Jun 30, 2023 | 4.11 Bn |
| Mar 31, 2023 | 3.98 Bn |
| Dec 31, 2022 | 3.85 Bn |
| Sep 30, 2022 | 3.95 Bn |
| Jun 30, 2022 | 4.03 Bn |
| Mar 31, 2022 | 3.92 Bn |
| Dec 31, 2021 | 3.99 Bn |
| Sep 30, 2021 | 4.26 Bn |